Know More about Pharmaceuticals Partnerships, Licensing, Investments and M&A Deals and Latest Trends

HTF Market Intelligence released a new research report of 87 pages on title 'Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals' with detailed analysis, forecast and strategies.

Request a sample report @ https://www.htfmarketreport.com/sample-report/1854981-partnerships-licensing-investments-and-m-a-deals-and-trends-45

Summary
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends for February 2019 in Pharmaceuticals", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in February 2019. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from GlobalData’s proprietary in-house Pharmaceuticals eTrack deals database and primary and secondary research.

Get Customization in the Report, Enquire Now @ https://www.htfmarketreport.com/enquiry-before-buy/1854981-partnerships-licensing-investments-and-m-a-deals-and-trends-45
Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, central nervous system, dermatology, ear nose throat disorders, gastrointestinal, genito urinary system and sex hormones, hematological disorders, hormonal disorders, immunology, infectious disease, male health, metabolic disorders, mouth and dental disorders, musculoskeletal, oncology, ophthalmology, respiratory, toxicology, and women's health segments.
- Analysis of partnerships, licensing, M&As, equity/debt offerings, private equity, and venture financing deals in the pharmaceutical industry.
- Analysis of therapy areas which are very active in terms of venture capital financing, partnerships, licensing agreements, equity/debt offerings, and M&As.
- Analysis of deals based on different payment modes, including upfront and milestone payments, primarily in partnerships and licensing agreements in the pharmaceutical industry.
- Analysis of partnership and licensing deals based on clinical stage of development of products.
- Summary of the pharmaceutical deals globally in the six months.
- Information on the top deals happened in the pharmaceutical industry.
- Geographies covered include - North America, Europe, Asia Pacific, South & Central America, and the Middle East & Africa.
- League tables of financial advisors in M&As and equity/debt offerings. This includes key advisors such as Morgan Stanley, Credit Suisse, and Goldman Sachs.

Reasons to buy

- Enhance your decision making capability in a more rapid and time sensitive manner.
- Find out the major deal performing segments for investments in your industry.
- Evaluate the types of companies which are entering into partnership or licensing agreements; divesting and acquiring assets.
- Identify companies that are aggressively looking to raise capital in the market
- Evaluate niche therapy areas that are receiving majority of the upfront and milestone payments in the pharmaceutical industry.
- Identify the key venture capitalists, who are financing the pharmaceutical and biotech companies.
- Evaluate the clinical development stages where majority of the partnerships and licensing agreements are happening.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the pharmaceutical industry.
- Identify growth segments and opportunities in each region within the industry.
- Look for key financial advisors where you are planning to raise capital from the market or for acquisitions within the industry.
Buy this report @ https://www.htfmarketreport.com/buy-now?format=1&report=1854981
1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, February 2019
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, February 2019
2.2.1 Danaher to Acquire Biopharma Business from General Electric for USD21.4 Billion
2.2.2 Takeda Pharma Files Shelf Registration Statement for Public Offering of Hybrid Bonds Due 2079 for USD4.52 Billion
2.2.3 Roche to Acquire Spark Therapeutics
2.2.4 GlaxoSmithKline and Merck Enter into Co-Development Agreement
2.2.5 Abpro and Jiangsu Chia-tai Tianqing Pharma Enter into Development Agreement
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, February 2019
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, February 2019
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
4 Pharmaceuticals & Healthcare, Global, Licensing Agreements, February 2019
....Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/1854981-partnerships-licensing-investments-and-m-a-deals-and-trends-45

Thanks for reading this article, you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

Craig Francis (PR & Marketing Manager)
HTF Market Intelligence Consulting Private Limited
Unit No. 429, Parsonage Road Edison, NJ
New Jersey USA – 08837
Phone: +1 (206) 317 1218
sales@htfmarketreport.com

HTF Market Report is a wholly owned brand of HTF market Intelligence Consulting Private Limited. HTF Market Report global research and market intelligence consulting organization is uniquely positioned to not only identify growth opportunities but to also empower and inspire you to create visionary growth strategies for futures, enabled by our extraordinary depth and breadth of thought leadership, research, tools, events and experience that assist you for making goals into a reality. Our understanding of the interplay between industry convergence, Mega Trends, technologies and market trends provides our clients with new business models and expansion opportunities. We are focused on identifying the “Accurate Forecast” in every industry we cover so our clients can reap the benefits of being early market entrants and can accomplish their “Goals & Objectives”.

This release was published on openPR.